- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07943208
Gluteus Maximus Transfer for Hip Abductor Insufficiency Following Total Hip Arthroplasty
Clinical and Functional Outcomes of Gluteus Maximus Transfer for the Management of Hip Abductor Insufficiency Following Total Hip Arthroplasty: A Clinical Study
Hip abductor insufficiency is a challenging complication following total hip arthroplasty (THA). It may result from damage to the abductor muscles or tendons, particularly the gluteus medius and minimus, and can lead to persistent hip pain, muscle weakness, a positive Trendelenburg sign, and impaired walking ability.
Gluteus maximus transfer is a surgical procedure used to restore the function of the hip abductor mechanism in patients with severe abductor insufficiency. This study aims to evaluate the clinical and functional outcomes of gluteus maximus transfer in patients who develop abductor insufficiency following total hip arthroplasty.
The study will assess postoperative improvements in hip function, abductor strength, gait, pain, and patient-reported functional outcomes, as well as the occurrence of postoperative complications. The hypothesis is that gluteus maximus transfer can provide meaningful functional improvement in appropriately selected patients with persistent abductor insufficiency following total hip arthroplasty.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
**Inclusion Criteria**
- Adult patients aged 18 years or older.
- Patients who underwent primary or revision total hip arthroplasty.
- Patients with symptomatic hip abductor insufficiency following total hip arthroplasty.
- Clinical evidence of abductor mechanism deficiency, including abductor weakness, positive Trendelenburg sign, or gait disturbance.
- Patients with irreparable or functionally deficient hip abductor mechanism considered suitable for gluteus maximus transfer.
- Availability of preoperative and postoperative clinical and functional assessment data.
**Exclusion Criteria**
- Active periprosthetic joint infection at the time of the planned procedure.
- Neurological disorders significantly affecting hip abductor function or gait.
- Severe gluteus maximus muscle dysfunction or insufficiency that precludes transfer.
- Severe medical comorbidities contraindicating surgery.
- Inadequate clinical follow-up or missing essential outcome data.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Gluteus Maximus Transfer
Patients with hip abductor insufficiency following total hip arthroplasty undergoing gluteus maximus transfer for reconstruction of the deficient hip abductor mechanism. |
Surgical transfer of the gluteus maximus muscle to reconstruct the deficient hip abductor mechanism in patients with persistent abductor insufficiency following total hip arthroplasty. The procedure aims to improve hip abductor function, pelvic stability, gait, and overall functional outcomes. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Hip Abductor Muscle Strength
Tidsramme: Preoperative assessment and 12 months postoperatively.
|
Assessment of hip abductor muscle strength before and after gluteus maximus transfer using manual muscle testing according to the Medical Research Council (MRC) grading scale (0-5). |
Preoperative assessment and 12 months postoperatively.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional Outcome - Harris Hip Score
Tidsramme: preoperative baseline to 12 months postoperatively
|
Change in Harris Hip Score from preoperative baseline to 12 months postoperatively to assess hip pain and function. |
preoperative baseline to 12 months postoperatively
|
|
Trendelenburg Sign
Tidsramme: preoperative and 12 month postoperative
|
Assessment of the presence or absence of Trendelenburg sign during clinical examination before and 12 month after surgery. |
preoperative and 12 month postoperative
|
|
Pain Assessment
Tidsramme: preoperative and 12 months postoperative
|
Change in hip pain intensity measured using the Visual Analog Scale (VAS). |
preoperative and 12 months postoperative
|
|
Postoperative Complications
Tidsramme: during the period of follow up 12 months postoperative
|
Documentation of postoperative complications, including persistent abductor weakness, infection, dislocation, wound complications, and revision surgery. |
during the period of follow up 12 months postoperative
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- asy453789
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .